RS

Ruby Singh

Active Director Director DIN 09433889
DIN 09433889 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Ruby Singh

Data last updated:

Ruby Singh is a Director at Zerachiel Healthcare Private Limited (since 2021). The company operates in Chemicals. Zerachiel Healthcare Private Limited reported revenue of ₹6 Lakh (FY 2024).

DIN 09433889
Primary Designation Director
Industry Chemicals
First Appointment 13 Dec 2021
Oldest Company Age 4 yrs
Largest company Zerachiel Healthcare Private Limited · ₹6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zerachiel Healthcare Private Limited U24239UP2021PTC156797
Director13 Dec 20212021₹6 Lakh (FY 2024)Active

Board colleagues of Ruby Singh

Directorship timeline

Open interactive timeline →
Zerachiel Healthcare Private Limited
Premium access

Shareholding and investment profile for Ruby Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ruby Singh

Ruby Singh currently holds 1 directorship: Zerachiel Healthcare Private Limited (Director, since 13 Dec 2021, revenue ₹6 Lakh (FY 2024)).

Ruby Singh was first appointed on 13 Dec 2021 as Director at Zerachiel Healthcare Private Limited.

The current boards of Ruby Singh's companies include Pradeep Kumar Singh (Zerachiel Healthcare Private Limited), Sanjay Kumar Singh (Zerachiel Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available